PPARA and metabolic dysfunction-associated steatohepatitis: Additionally, PPARα plays a role in inhibiting hepatic inflammation, reducing liver fibrosis, and preventing hepatic steatosis, thereby mitigating the progression of MASLD and NASH (56).